Mckesson Corporation
Mckesson Corporation is a global leader in the distribution of pharmaceutical products and the provision of technology solutions for the healthcare sector.
Price history of Mckesson Corporation
Price history of Mckesson Corporation
Performance & Momentum
McKesson Posts Strong Q3, Maintains Buy Despite Sector Drop
McKesson Corporation (Mckesson Corporation) reported a solid third quarter in 2026 with revenues of $106.16 billion and net income of $1.19 billion. The company continued shareholder returns through share buybacks and a quarterly dividend of $0.82. Bank of America upheld its buy rating, raising the price target to $970, highlighting the stock's strong performance in recent months. However, the pharmaceutical distribution sector is under pressure, with McKesson shares down about 4%, reflecting broader declines in logistics and pharmaceutical stocks amid AI-related concerns.
Strategic Analysis
Mckesson Corporation • 2026
McKesson holds a central position in the U.S. healthcare value chain through its pharmaceutical distribution and related services businesses. Its model is based on high volumes, critical logistics, and a structural presence alongside hospitals, pharmacies, and healthcare providers, making it a defensive stock but one that is highly exposed to margin dynamics in a very competitive industry.
- Indispensable role in the distribution of medicines and medical products, with structurally sustained demand
- Diversification into healthcare services, which strengthens the depth of the model beyond pure logistics
- Very strong stock market performance over several years, reflecting solid operational execution and positive market perception
- Business with generally low margins, sensitive to competitive pressure and the bargaining power of customers and suppliers
- Dependence on the regulatory framework and changes in the U.S. healthcare system, which may weigh on visibility
Momentum appears broadly favorable, with an underlying trend still constructive despite a more hesitant recent phase. After a short-term consolidation, the stock retains market momentum above that of a simple defensive name, suggesting continued investor interest in its quality profile and resilience.
Similar stocks to Mckesson Corporation
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
